Trial intelligence / Profile preview

Monofer versus placebo in iron-deficient female first-time blood donors

2010-023790-19Phase 4Terminated

Sponsor
Rigshospitalet
Start
Aug 2011
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Monofer with Placebo (2 arms). Primary endpoint: Change in hemoglobin concentration from baseline to before third donation. Started Aug 2011; status: terminated.

02

Drugs

ferric derisomaltose
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on 2010-023790-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-023790-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call